BETHLEHEM, Pa.--(BUSINESS WIRE)--Neuromonics, Inc. today announced that it has been designated to receive $1 million in funding through the Department of Defense to study the treatment of tinnitus among military servicemembers. The Neuromonics Tinnitus Treatment is a clinically proven treatment, offering long-term relief by comprehensively targeting the neurological root causes of tinnitus.
